SpOtOn Clinical Diagnostics, a spin-out from King’s College, London, and Evelina Children’s Hospital, provides technology based on 30 years experience developing mass spectrometry in clinical biochemistry.

Its patent-protected innovations enable the:

• Adoption of Mass Spectrometry for newborn and ante-natal screening for haemoglobinopathies


• Tracking of kidney function based on the in-depth knowledge gleaned from supporting the world-leading paediatric renal service at Evelina Children’s Hospital


• Screening for and monitoring inherited metabolic diseases

SpOtOn’s technology reduces costs and complexity by an order of magnitude, creating significant economies of scale, and favouring early adopters. SpOtOn supplies reagents, consultancy and outsourced testing.